On May 13, 2015, an affidavit or declaration regarding plan of liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1319 and is described on the court’s official docket as follows:
Affidavit of Paul D. Moore /Declaration of Chapter 11 Trustee in Support of Confirmation of Second Amended Joint Chapter 11 Plan of New England Compounding Pharmacy, Inc. with certificate of service (Re:  Notice) filed by Trustee Paul D. Moore (Lastowski, Michael)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.